Target intelligence / Profile preview

Mitofusin-1 (MFN1)

Target
MFN1
Molecular classification
GTPase enzyme, Dynamin superfamily member, Mitochondrial outer membrane protein
01

Overview

Mitofusin-1 (MFN1) is a mitochondrial outer membrane GTPase essential for the process of mitochondrial fusion and maintenance of mitochondrial network morphology[3][4]. Along with its paralog mitofusin-2 (MFN2), it mediates the tethering and subsequent fusion of the outer membranes of adjacent mitochondria through GTP-dependent oligomerization and conformational changes[1][2][4]. Structurally, MFN1 contains an N-terminal GTPase domain, a transmembrane domain that anchors it in the outer mitochondrial membrane, and two heptad repeat coiled-coil domains (HR1 and HR2) critical for membrane tethering and fusion[1][2][4]. By regulating mitochondrial morphology, MFN1 influences important cellular processes such as energy production, apoptosis, cell proliferation, and signaling[1][2][3][4]. Both loss and gain of MFN1 function are linked to pathological conditions including neurodegenerative disorders and cardiovascular disease, highlighting its role as a potential therapeutic target[2][4][5]. Small molecules such as MASM7 have been identified that can activate MFN1, promoting mitochondrial fusion, serving as potential tools for modulating mitochondrial dynamics in disease contexts[2].

Other names
Mitofusin-1MFN1Fzo homologTransmembrane GTPase MFN1hfzo1hfzo2mitochondrial transmembrane GTPase FZO-2mitochondrial transmembrane GTPase Fzo-1putative transmembrane GTPaseFLJ20693
02

Mechanism of action

Activation or inhibition of mitochondrial fusion via direct modulation of MFN1 oligomerization and conformational state[2]

03

Biological functions

Mitochondrial fusionMitochondrial membrane tetheringRegulation of mitochondrial morphologyModulation of mitochondrial clustering and distribution
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseMetabolic disordersOther diseases involving mitochondrial dysfunction
05

Safety considerations

Potential risk of disturbing mitochondrial dynamics leading to unwanted mitochondrial fragmentation or fusionMitochondrial dysfunction implicated in cell death and degenerative disease
06

Interacting drugs

MASM7

Beyond the preview

Go deeper on Mitofusin-1 (MFN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitofusin-1 (MFN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call